Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Linaclotide.

Client Email

Product

Linaclotide
HEALTH CANADA PATENTS

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Linaclotide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 12 USDMF, 1 JDMF, 2 EU WC, 6 NDC API, 20 Listed Suppliers, $ API Reference Price

30 API Suppliers
12 USDMF
1 JDMF
2 EU WC
6 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 8 FDA Orange Book, 8 Europe, 3 Canada, 5 Listed Dossiers

24 FDF Dossiers
8 FDA Orange Book
8 Europe
3 Canada
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 145MCG, CAPSULE;ORAL - 290MCG, CAPSULE;ORAL - 72MCG

CAPSULE;ORAL - 145MCG
CAPSULE;ORAL - 290MCG
CAPSULE;ORAL - 72MCG

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 SPI Pharma, 6 DKSH, 6 Gangwal Healthcare, 1 Pfanstiehl, 4 ACG Worldwide, 1 Actylis, 1 Aeon Procare, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 9 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Vasa Pharmachem

1 Evonik
1 SPI Pharma
6 DKSH
6 Gangwal Healthcare
1 Pfanstiehl
4 ACG Worldwide
1 Actylis
1 Aeon Procare
2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
10 Corel Pharma Chem
2 DFE Pharma
1 Finar
6 Gangwal Chemicals
7 Ideal Cures Pvt Ltd
17 Kerry
3 Kima Chemical
6 Lonza Capsugel
4 Microlex e.U
2 Novo Excipients
1 Pharmatrans-Sanaq
1 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
2 Qualicaps
9 Roquette
6 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
9 Sigachi Industries
2 The Dow Chemical Company
1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

49 Coating Systems & Additives, 24 Controlled & Modified Release, 24 Fillers, Diluents & Binders, 14 Thickeners and Stabilizers, 14 Direct Compression, 9 Empty Capsules, 8 Co-Processed Excipients, 7 Film Formers & Plasticizers, 7 Disintegrants & Superdisintegrants, 7 Granulation, 5 Lubricants & Glidants, 5 Taste Masking, 4 Parenteral, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Coloring Agents, 3 Chewable & Orodispersible Aids, 2 Topical, 2 Rheology Modifiers, 1 Solubilizers, 1 Emulsifying Agents

49 Coating Systems & Additives
24 Controlled & Modified Release
24 Fillers, Diluents & Binders
14 Thickeners and Stabilizers
14 Direct Compression
9 Empty Capsules
8 Co-Processed Excipients
7 Film Formers & Plasticizers
7 Disintegrants & Superdisintegrants
7 Granulation
5 Lubricants & Glidants
5 Taste Masking
4 Parenteral
4 Vegetarian Capsules
4 API Stability Enhancers
4 Coloring Agents
3 Chewable & Orodispersible Aids
2 Topical
2 Rheology Modifiers
1 Solubilizers
1 Emulsifying Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 45 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
45 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 10 Finished Drug Prices, 15 Annual Reports

1 US Medicaid Prescriptions
10 Finished Drug Prices
15 Annual Reports

MARKET PLACE

11 APIs

11 APIs

PATENTS & EXCLUSIVITIES

40 US Patents, 2 US Exclusivities, 2 Health Canada Patents

40 US Patents
2 US Exclusivities
2 Health Canada Patents

$ API Ref.Price (USD/KG) : 878,655 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2AbbVie Corporation

filter Patent Reset all filters

2 All

01 22514507

filter Product Reset all filters

2 All

01 2LINACLOTIDE

filter Dosage Reset all filters

2 All

01 2CAPSULE

filter Exp Date Reset all filters

2 All

01 22024-01-28

US Patents
US Exclusivities
Health Canada Patents

Product Main Page

01

AbbVie Corporation

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

Linaclotide

Brand Name : CONSTELLA

Patent Number : 2514507

Filing Date : 2004-01-28

Strength per Unit : 145 ?g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AbbVie Corporation

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

Linaclotide

Brand Name : CONSTELLA

Patent Number : 2514507

Filing Date : 2004-01-28

Strength per Unit : 290 ug

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?